Taveras Arthur
X4 Pharmaceuticals, Inc. · Chief Scientific Officer
Taveras Arthur is listed in filings as Chief Scientific Officer at X4 Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Oct 8, 2024, including sale activity. Recent filings connect the profile to X4 Pharmaceuticals, Inc. (XFOR). The current snapshot covers public activity from Oct 8, 2024. Reported amounts are shown as $43.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||